echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Norepinephrine bitartrate injection, a subsidiary of Tianyao Pharmaceutical, passed the consistency evaluation

    Norepinephrine bitartrate injection, a subsidiary of Tianyao Pharmaceutical, passed the consistency evaluation

    • Last Update: 2021-12-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On November 18, Tianyao Pharmaceutical issued an announcement stating that its subsidiary Jinyao Pharmaceutical had received the "Drug Supplementary Application Approval Notice" for norepinephrine bitartrate injection approved and issued by the National Medical Products Administration, and approved it The drug passed the quality and efficacy consistency evaluation of generic drugs


    Norepinephrine bitartrate injection belongs to the category of "National Essential Drug List (2018)", "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2020)" Category A variety, clinically necessary and easy to shortage drugs


    At present, there are 7 companies in the domestic market whose norepinephrine bitartrate injections have been approved for listing.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.